| Terri S Adoff, RN | |
|
132 Canterbury Dr, Kettering, OH 45429-1402 | |
| (937) 475-1090 | |
| Not Available |
| Full Name | Terri S Adoff |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Home Health |
| Location | 132 Canterbury Dr, Kettering, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235640483 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WM0102X | Registered Nurse - Maternal Newborn | RN.327823 (Ohio) | Secondary |
| 163WH0200X | Registered Nurse - Home Health | RN.327823 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Terri S Adoff, RN 601 S Edwin C Moses Blvd, Dayton, OH 45417-3424 Ph: (937) 734-8333 | Terri S Adoff, RN 132 Canterbury Dr, Kettering, OH 45429-1402 Ph: (937) 475-1090 |
News Archive
The Centers for Disease Control and Prevention is launching a new antibiotic tracking system allowing hospitals to monitor antibiotic use electronically, make better decisions about how to improve use, and compare themselves to other hospitals. Before now, CDC was only able to track antibiotic use in doctors' offices.
Excelitas Technologies® Corp. and Quorum Technologies will present a webinar entitled "How Can I Build a Microscopy System for Optogenetics?" led by featured speakers Kavita Aswani, Ph.D., senior applications scientist for the Life Sciences products at Excelitas Technologies, and Ryan Geil, M.Sc., service manager at Quorum Technologies Inc. The session will be moderated by Photonics Media and takes place on Thursday, November 12 at 1:00 pm (EST).
New research has highlighted stark disparities in access to the latest cancer drugs across European Union nations, according to data presented at the 33rd Congress of the European Society for Medical Oncology (ESMO) in Stockholm.
The first test to quickly and accurately predict how people will respond to standard treatment for the most common type of leukemia has been developed at Cardiff University. The technology could guide doctors' decisions on which drugs to give to patients.
Santarus, Inc., a specialty biopharmaceutical company, today announced that it has initiated a Phase I clinical study with SAN-300, its anti-VLA-1 antibody.
› Verified 4 days ago
Susan Kay Zann, RNFS Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3535 Southern Blvd, Kettering, OH 45429 Phone: 937-395-8608 | |
Joan S Koble, CRNFA Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3535 Southern Blvd, Kettering, OH 45429 Phone: 937-298-4331 | |
Mrs. Erica R Gwin, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3148 Larue Dr, Kettering, OH 45429 Phone: 937-789-0579 | |
Tiffany Thompson, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1256 Robert Dickey Pkwy, Kettering, OH 45409 Phone: 937-694-6156 | |
Leigh Obie, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 5462 Montgomery Square Dr, Kettering, OH 45440 Phone: 937-329-1051 | |
Robyn Avery Michael, REGISTERED NURSE Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2632 Woodman Center Ct, Kettering, OH 45420 Phone: 937-739-7100 Fax: 480-687-7361 | |
Mrs. Deborah Ann Wise, CNS Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 3700 Southern Blvd Ste 401, Kettering, OH 45429 Phone: 855-500-2873 Fax: 937-281-3913 |